Towards Healthcare
Liver Cancer Drugs Market Size Envisioned at USD 9.94 Billion by 2032

Liver Cancer Drugs Market Size Envisioned at USD 9.94 Billion by 2032

The report covers Liver Cancer Drugs Market Size and Companies such as Bayer AG, Bristol-Myers Squibb Company, Eisai Co., Ltd., Exelixis, Inc., Merck KGaA, Pfizer Inc., Eisai Inc., Eli Lilly and Company and F. Hoffmann-La Roche Ltd. offering a range of therapies. The market is segmented by drug class, including chemotherapy, targeted therapy, immunotherapy and others. Distribution channels include hospitals, clinics, retail pharmacies and online pharmacies. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Liver Cancer Drugs Market Assessment

  • Overview
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • South America

North America Liver Cancer Drugs Market Assessment

  • Overview
  • North America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • North America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Europe Liver Cancer Drugs Market Assessment

  • Overview
  • Europe Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Europe Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Asia Pacific Liver Cancer Drugs Market Assessment

  • Overview
  • Asia Pacific Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Asia Pacific Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Middle East and Africa Liver Cancer Drugs Market Assessment

  • Overview
  • Middle East and Africa Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • Middle East and Africa Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

South America Liver Cancer Drugs Market Assessment

  • Overview
  • South America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Class (2021 – 2033)
    • Targeted Therapy 
      • Bevacizumab
      • Cabozantinib
      • Lenvatinib
      • Ramucirumab
      • Regorafenib
      • Sorafenib
      • Other Targeted Therapies
    • Immunotherapy 
      • Atezolizumab with Bevacizumab
      • Nivolumab with Ipilimumab
      • Pembrolizumab
      • Durvalumab with Tremelimumab
      • Other Immunotherapies
    • Chemotherapy 
      • Gemcitabine
      • Oxaliplatin
      • Cisplatin
      • Doxorubicin
      • 5-fluorouracil
      • Capecitabine
      • Mitoxantrone
      • Other Chemotherapies
  • South America Liver Cancer Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Company Profiles

  • Bayer AG
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Merck KGaA
  • Pfizer Inc.
  • Eisai Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.

Conclusion & Recommendations

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

In the upcoming years, the liver cancer drugs market is anticipated to rise significantly due to factors like increased research and development, an expanding patient base, and an emphasis on personalized therapy.

Some major obstacles to the approval of new drugs are as follows: Safety-related issues: Carefully assessing the possible adverse effects of novel medications is necessary. Authorities that oversee cost-effectiveness consider the potential advantages of a treatment about its cost.

Despite recent progress, liver cancer treatment still needs a great deal of improvement. These unfulfilled needs include: improved medications for advanced hepatic carcinoma decreased adverse effects and increased efficacy, early identification, and diagnosis.

Global Cancer Observatory, American Liver Foundation, World Health Organization, National Institute of Health.